Article info

Download PDFPDF

Whole-blood RNA transcript-based models can predict clinical response in two large independent clinical studies of patients with advanced melanoma treated with the checkpoint inhibitor, tremelimumab

Authors

  1. a philip.friedlander{at}mssm.edu
  2. b karl.wassmann{at}cpscdx.com
  3. c alan.christenfeld{at}cpscdx.com
  4. d dfisher3{at}mgh.harvard.edu
  5. e chrisann.kyi{at}gmail.com
  6. f kirkwoodJM{at}upmc.edu
  7. g nina.bhardwaj{at}mssm.edu
  8. h william.oh{at}mssm.edu
View Full Text

Citation

Friedlander P, Wassmann K, Christenfeld AM, et al
Whole-blood RNA transcript-based models can predict clinical response in two large independent clinical studies of patients with advanced melanoma treated with the checkpoint inhibitor, tremelimumab

Publication history

  • Received May 4, 2017
  • Accepted August 1, 2017
  • First published August 15, 2017.
Online issue publication 
August 15, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.